Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opioids for agitation in dementia.

Richard Brown1, Robert Howard, Bridget Candy

  • 1Community Mental Health Team for Older People, Kent and Medway NHS Partnership Trust, Gregory House, Littlebourne Road, Canterbury, Kent, UK, CT1 1TD.

The Cochrane Database of Systematic Reviews
|May 15, 2015
PubMed
Summary

Current research shows insufficient evidence on the clinical efficacy and safety of opioid medications for agitation in dementia patients. More studies are needed to determine if opioids help or worsen agitation in this population.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prevalence and incidence of delirium superimposed on dementia in community settings: A systematic review and meta-analysis.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Impact of home healthcare reform on place of death for people with dementia: A nationwide cohort study accounting for cultural factors of impending death discharge - CORRIGENDUM.

Palliative & supportive care·2026
Same author

Increasing number of unmanaged distressing symptoms in people living with dementia associated with family carer burden and distress following an unplanned hospital admission: A longitudinal cohort study.

Palliative care and social practice·2026
Same author

Impact of home healthcare reform on place of death for people with dementia: A nationwide cohort study accounting for cultural factors of impending death discharge.

Palliative & supportive care·2026
Same author

Palliative care symptoms of people living with rapidly progressive prion diseases: a systematic review.

BMC palliative care·2026
Same author

Delirium, long-term conditions, and incident dementia in older adults admitted to hospital for emergency care in Lothian, Scotland: a population-based cohort study.

The lancet. Healthy longevity·2026

Area of Science:

  • Geriatric Medicine
  • Neuroscience
  • Pharmacology

Background:

  • Agitation is a prevalent symptom in dementia patients, often worsening with cognitive decline.
  • Limited pharmacological options exist for managing dementia-related agitation.
  • The safety and efficacy of opioid use for agitation in dementia remain largely unknown.

Purpose of the Study:

  • To evaluate the clinical effectiveness and safety of opioid medications for managing agitation in individuals with dementia.

Main Methods:

  • A comprehensive literature search was conducted using terms related to opioids and agitation in dementia.
  • The search included major databases and trial registries via the ALOIS specialized register.
  • Inclusion criteria focused on randomized, placebo-controlled trials comparing opioids to placebo for agitation in dementia.

Related Experiment Videos

Main Results:

  • No completed randomized, placebo-controlled trials investigating opioid use for agitation in dementia were identified.
  • Two relevant trials are currently ongoing and may provide future insights.

Conclusions:

  • There is insufficient evidence to confirm the clinical efficacy and safety of opioids for agitation in dementia.
  • Further research is essential to understand whether opioids alleviate or exacerbate agitation in dementia patients.
  • More data is required to guide the safe and effective use of opioids in dementia care.